MétaCan
Menu
Back to cohort
Record W3087062954 · doi:10.1111/ajt.16311

A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation

2020· article· en· W3087062954 on OpenAlexafffund
Peter Nickerson, Robert Balshaw, Chris Wiebe, Julie Ho, Ian W. Gibson, Nancy D. Bridges, David N. Rush, Peter S. Heeger

Bibliographic record

VenueAmerican Journal of Transplantation · 2020
Typearticle
Languageen
FieldMedicine
TopicRenal Transplantation Outcomes and Treatments
Canadian institutionsUniversity of ManitobaGeorge & Fay Yee Centre for Healthcare InnovationHealth Sciences Centre
FundersInstitute of Nutrition, Metabolism and DiabetesNational Institute of Allergy and Infectious DiseasesCanadian Institutes of Health ResearchDivision of Intramural Research, National Institute of Allergy and Infectious Diseases
KeywordsMedicineCalcineurinKidney transplantationTransplantationUrologySubstitution (logic)OncologyClinical trialInternal medicinePharmacologyIntensive care medicine

Abstract

fetched live from OpenAlex

Improving long-term kidney transplant outcomes requires novel treatment strategies, including delayed calcineurin inhibitor (CNI) substitution, tested using informative trial designs. An alternative approach to the usual superiority-based trial is a noninferiority trial design that tests whether an investigational agent is not unacceptably worse than standard of care. An informative noninferiority design, with biopsy-proven acute rejection (BPAR) as the endpoint, requires determination of a prespecified, evidence-based noninferiority margin for BPAR. No such information is available for delayed CNI substitution in kidney transplantation. Herein we analyzed data from recent kidney transplant trials of CNI withdrawal and "real world" CNI- based standard of care, containing subjects with well-documented evidence of immune quiescence at 6 months posttransplant-ideal candidates for delayed CNI substitution. Our analysis indicates an evidence-based noninferiority margin of 13.8% for the United States Food and Drug Administration's composite definition of BPAR between 6 and 24 months posttransplant. Sample size estimation determined that ~225 randomized subjects would be required to evaluate noninferiority for this primary clinical efficacy endpoint, and superiority for a renal function safety endpoint. Our findings provide the basis for future delayed CNI substitution noninferiority trials, thereby increasing the likelihood they will provide clinically implementable results and achieve regulatory approval.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.266
metaresearch head score (Gemma)0.213
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.266
Threshold uncertainty score0.905

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2660.213
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0030.007
Bibliometrics0.0010.001
Science and technology studies0.0010.003
Scholarly communication0.0020.004
Open science0.0020.002
Research integrity0.0050.006
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.316
Teacher spread0.277 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueAmerican Journal of TransplantationSame topicRenal Transplantation Outcomes and TreatmentsFrench-language works237,207